Navigenics provide personalized genetic analysis to empower individuals to act based on an understanding of their
genetic predispositions.
The company's mission is to improve health outcomes across the population by providing clinically actionable genetic
insights to motivate behavior change.
The company was founded in 2006 by David Agus, M.D., an oncologist, and Dietrich Stephan, Ph.D., a human geneticist,
with the overall goal of improving personal health. Navigenics' genetic testing services were born out of scientific
discoveries initially made possible by the Human Genome Project, a 13-year federal and international collaboration to
identify every single human gene.
The company believes that genetic testing and analysis will become the foundation and standard of care that will make
personalized medicine a reality. This outcome is best pursued by working closely with state and federal regulators to set
industry standards for personal genomic testing services.
This report offer an analysis of Navigenics' market and competitiors |
